Aldeyra Therapeutics, Inc. Income Statement

Income Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.16M-0.24M-0.11M-0.11M-0.11M-0.15M-0.60M-1.90M-1.74M-1.69M-2.07M-1.93M
Gross Profit -0.16M-0.24M-0.11M-0.11M-0.11M-0.15M-0.60M-1.90M-1.74M-1.69M-2.07M-1.93M
Operating items
Research & Development 1.54M3.71M7.57M13.18M16.30M29.82M44.35M24.68M44.94M47.31M29.46M48.22M
Selling, General & Administrative 2.13M3.56M4.41M5.52M6.19M9.88M12.15M9.99M11.28M15.37M13.34M11.89M
Other Operating Expenses -3.49M-7.09M-11.52M-18.14M-21.72M
Operating Expenses 0.19M0.18M0.47M0.55M0.77M39.70M56.51M34.67M56.22M62.68M42.79M60.12M
Operating Income -3.68M-7.27M-11.99M-18.70M-22.49M-39.70M-63.07M-36.42M-56.22M-62.68M-42.79M-60.12M
EBIT -3.68M-7.27M-11.99M-18.70M-22.49M-39.70M-63.07M-36.42M-56.22M-62.68M-42.79M-60.12M
Non-operating items
Interest & Investment Income 0.00M0.00M0.01M0.10M0.26M0.95M1.54M0.29M0.19M2.35M7.32M6.19M
Other Non Operating Income 16.18M2.33M
Non Operating Income 16.74M2.08M-0.10M-0.00M0.15M0.81M0.94M-1.61M-1.56M0.66M5.25M4.27M
Net income details
EBT -3.84M-7.51M-12.09M-18.70M-22.34M-38.89M-62.14M-38.03M-57.78M-62.02M-37.54M-55.85M
Tax Provisions -1.31M-0.48M
Profit After Tax 13.06M-5.19M-12.09M-18.70M-22.34M-38.89M-60.83M-37.60M-57.80M-62.02M-37.54M-55.90M
Income from Continuing Operations -3.84M-7.51M-12.09M-18.70M-22.34M-38.89M-60.83M-37.55M-57.78M-62.02M-37.54M-55.85M
Consolidated Net Income -3.84M-7.51M-12.09M-18.70M-22.34M-38.89M-60.83M-37.55M-57.78M-62.02M-37.54M-55.85M
Income towards Parent Company -3.84M-7.51M-12.09M-18.70M-22.34M-38.89M-60.83M-37.55M-57.78M-62.02M-37.54M-55.85M
Preferred Dividend Payments 11.13M4.05M
Net Income towards Common Stockholders -15.07M-9.57M-12.09M-18.70M-22.34M-38.89M-60.83M-37.55M-57.78M-62.02M-37.54M-55.85M
Additional items
EPS (Basic) 0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 5.17M5.57M9.71M12.58M19.12M26.24M27.95M38.82M58.09M58.56M58.82M59.55M
EBITDA -3.68M-7.27M-11.99M-18.70M-22.49M-39.70M-63.07M-36.42M-56.22M-62.68M-42.79M-60.12M
Tax Rate 2.11%1.26%